Acadian Asset Management »

Eliem Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $59k 4.5k 13.02

More positions owned by Acadian Asset Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Bk Nova Cad (BNS)
Applied Materials (AMAT)
Micron Technology (MU)
Cibc Cad (CM)
Meta Platforms Cl A (META)
Costco Wholesale Corporation (COST)
Broadcom Ord Shs (AVGO)
Kla Corp Com New (KLAC)
Alphabet Cap Stk Cl C (GOOG)
Asml Hldg Nv N Y Registry Shs (ASML)

View all positions for Acadian Asset Management

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics